Position in ASND
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,453,890
New position
Shares Held
20,448
first reported quarter
Ownership
0.031%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#118
of 307 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tredje AP-fonden holds $108,189,503 across 9 Biotechnology names. ASND ranks #6 (5.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
48,079 | $29,979,179 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
59,459 | $29,535,069 | |
| 3 | RPRX |
Royalty Pharma plc
|
219,990 | $12,334,839 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
37,206 | $11,200,122 | |
| 5 | INCY |
Incyte Corp
|
67,814 | $7,687,395 | |
| 6 | ASND |
Ascendis Pharma A/S
This page
|
20,448 | $5,453,890 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
27,000 | $5,056,560 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
60,944 | $3,487,215 |
All Filings in ASND
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,453,890 | 20,448 | Shares | Sole | 2026-08-10 | |
| No filing history on record for this holder in this stock. | ||||||